D.E. Shaw & Co’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-52,462
| Closed | -$159K | – | 4323 |
|
|
2022
Q2 | $159K | Buy |
+52,462
| New | +$159K | ﹤0.01% | 3453 |
|
|
2022
Q1 | – | Sell |
-68,776
| Closed | -$574K | – | 4641 |
|
|
2021
Q4 | $574K | Buy |
68,776
+34,388
| +100% | +$287K | ﹤0.01% | 3029 |
|
|
2021
Q3 | $256K | Sell |
34,388
-44,535
| -56% | -$332K | ﹤0.01% | 3141 |
|
|
2021
Q2 | $537K | Buy |
+78,923
| New | +$537K | ﹤0.01% | 2862 |
|
|
2020
Q3 | – | Sell |
-24,367
| Closed | -$168K | – | 2864 |
|
|
2020
Q2 | $168K | Buy |
+24,367
| New | +$168K | ﹤0.01% | 2480 |
|
|
2020
Q1 | – | Sell |
-34,068
| Closed | -$298K | – | 2933 |
|
|
2019
Q4 | $298K | Sell |
34,068
-132,970
| -80% | -$1.16M | ﹤0.01% | 2363 |
|
|
2019
Q3 | $557K | Buy |
167,038
+33,595
| +25% | +$112K | ﹤0.01% | 2055 |
|
|
2019
Q2 | $660K | Sell |
133,443
-40,365
| -23% | -$200K | ﹤0.01% | 2039 |
|
|
2019
Q1 | $1.08M | Buy |
173,808
+80,032
| +85% | +$496K | ﹤0.01% | 1823 |
|
|
2018
Q4 | $316K | Buy |
93,776
+24,572
| +36% | +$82.8K | ﹤0.01% | 2230 |
|
|
2018
Q3 | $450K | Buy |
+69,204
| New | +$450K | ﹤0.01% | 2124 |
|
|
2018
Q2 | – | Sell |
-30,879
| Closed | -$690K | – | 2755 |
|
|
2018
Q1 | $690K | Buy |
+30,879
| New | +$690K | ﹤0.01% | 1966 |
|
|
2017
Q3 | – | Sell |
-19,323
| Closed | -$271K | – | 2655 |
|
|
2017
Q2 | $271K | Sell |
19,323
-917
| -5% | -$12.9K | ﹤0.01% | 2170 |
|
|
2017
Q1 | $445K | Buy |
+20,240
| New | +$445K | ﹤0.01% | 2021 |
|